Orbis Medicines, a leader in oral macrocycle drug discovery, today announces the appointment of Mikael Dolsten, M.D., Ph.D., former Chief Scientific O ...
At therapeutic doses, Sotyktu does not inhibit JAK1, JAK2 or JAK3. Sotyktu is approved ... postmarketing safety trial of a JAK inhibitor in rheumatoid arthritis (RA), patients 50 years of age ...
Olumiant is also approved to treat rheumatoid arthritis and some hospitalised ... positive results in the pivotal ALLEGRO trial of its JAK3 inhibitor ritlecitinib in alopecia, with a filing ...
The European Commission has cleared the dual inhibitor (JAK3 and TEC), given as a once ... to treat other conditions, including rheumatoid arthritis and atopic dermatitis, and sales were in ...
A Western Australian study reveals that rheumatoid arthritis patients have a lower overall cancer incidence but face higher ...
High antibody titers of anti–citrullinated peptide antibodies, rheumatoid factor, and certain baseline factors predict RA ...
A significant percentage of patients with RA and ANCA positivity were also diagnosed with AAV, with GPA being the most common subtype.
The following is a summary of “Value of lung ultrasonography for screening interstitial lung disease in patients with ...
Janus kinase inhibitor cycling may be more effective than switching to bDMARDs among patients with RA who had an inadequate response to initial JAK inhibitor therapy.
The Ra Ra Room, located on the event level of the recently renamed PHX Arena (formerly Footprint Center), will be open during Suns home games, select Phoenix Mercury games, concerts and weekend ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback